CH · biotech · healthcare · pharmaceutical
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · May 2025 · $130M
Novo Holdings lead, Qatar Investment Authority (QIA), Sofinnova Partners, LifeArc Ventures, Bristol Myers Squibb, Catalio Capital, Roche Ventures
Reported by TechStartups
Missing a round, or an investor who was in one? Tell us.